CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 69 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q4 2020. The put-call ratio across all filers is 57.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $81,356 | +17.3% | 4,436 | +1.2% | 0.00% | 0.0% |
| Q1 2020 | $69,355 | -14.1% | 4,384 | -4.1% | 0.00% | -50.0% |
| Q4 2018 | $80,759 | -49.8% | 4,573 | -47.1% | 0.00% | +100.0% |
| Q1 2016 | $161,000 | -5.8% | 8,651 | +8.9% | 0.00% | 0.0% |
| Q4 2015 | $171,000 | +13.2% | 7,946 | -11.1% | 0.00% | 0.0% |
| Q3 2015 | $151,000 | -54.5% | 8,941 | +0.9% | 0.00% | -50.0% |
| Q2 2015 | $332,000 | – | 8,863 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|